Shares of medical diagnostics company Precipio soar 40% ahead of commercialization as rapid COVID test available on Amazon – fr

Ocugen stock is on the rise after sharing a pre-impression on the effectiveness of the COVID-19 vaccine against a lesser-known Brazilian variant

Actions de microcap Precipio Inc. PRPO,
+ 171,98%,
a specialty diagnostics company, soared 41% in pre-market commerce on Tuesday, adding to gains of more than 170% on Monday, after the company said its rapid COVID-19 antibody test was now available on AMZN from,
business platform. The 20-minute test, which received emergency use clearance from the United States Food and Drug Administration in December, can only be purchased by qualified medical providers. “Doctors and other medical facilities can now purchase these items directly from Amazon and receive them within 2 business days,” the company said in a statement Monday. The test can identify the presence of antibodies that have been developed as a result of exposure to the coronavirus-transmitted disease or vaccination and show an immune response. “Antibodies are the body’s natural biological response to infection or vaccination, and their development begins the process of building the body’s immunity to protect against future infections,” Precipio said in the statement. The stock has gained 139% year-to-date, while the S&P 500 SPX,
+ 0,27%
gained 11.6%.


Please enter your comment!
Please enter your name here